Kidney transplant and Focal segmental glomerulosclerosis

Summary:

Focal segmental glomerulosclerosis is found among people with Kidney transplant, especially for people who are male, 30-39 old.

The study analyzes which people have Focal segmental glomerulosclerosis with Kidney transplant. It is created by eHealthMe based on reports of 240 people who have Kidney transplant from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Kidney transplant?

Kidney transplant is found to be associated with 299 drugs and 549 conditions by eHealthMe. Check the latest studies of Kidney transplant.

What is Focal segmental glomerulosclerosis?

Focal segmental glomerulosclerosis (scar tissue that forms in parts of the kidney called glomeruli) is found to be associated with 176 drugs and 397 conditions by eHealthMe. Check the latest studies of Focal segmental glomerulosclerosis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 21, 2026

240 people who have Kidney Transplant and Focal Segmental Glomerulosclerosis are studied.

Would you have Focal segmental glomerulosclerosis when you have Kidney transplant?

Gender of people who have Kidney transplant and experienced Focal segmental glomerulosclerosis *:

Click here to view

Age of people who have Kidney transplant and experienced Focal segmental glomerulosclerosis *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Focal segmental glomerulosclerosis?

- Check whether Focal segmental glomerulosclerosis is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Kidney transplant (48,961 reports)
Focal segmental glomerulosclerosis (2,786 reports)

All the drugs that are associated with Focal segmental glomerulosclerosis:

Focal segmental glomerulosclerosis (176 drugs)

All the conditions that are associated with Focal segmental glomerulosclerosis:

Focal segmental glomerulosclerosis (397 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Focal segmental glomerulosclerosis and Kidney transplant, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.